Overall survival
Intensive follow‐up showed no clear difference in overall survival compared with less intensive follow‐up (high certainty).
1 finding from 1 review
Colorectal cancer‐specific survival
Intensive follow‐up showed no clear difference in colorectal cancer‐specific survival compared with less intensive follow‐up (moderate certainty).
1 finding from 1 review
Proportion of participants with relapse‐free survival at ≥ 12 months
Intensive follow‐up showed no clear difference in relapse‐free survival compared with less intensive follow‐up (high certainty).
1 finding from 1 review
Salvage surgery (SS)
Intensive follow‐up leads to higher salvage surgery (surgery at relapse with curative intent) compared with less intensive follow‐up (high certainty).
1 finding from 1 review
Interval recurrences (IR)
Intensive follow‐up probably leads to lower interval recurrences (recurrence CRC diagnosed between scheduled compared with less intensive follow‐up (moderate certainty).
1 finding from 1 review
Harms Colonoscopy complications ‐ bowel perforation
It is very uncertain whether intensive follow‐up changes harms Colonoscopy complications ‐ bowel perforation compared with less intensive follow‐up (very low certainty).
1 finding from 1 review
Health‐related quality of life (HRQoL) · adult survivors of the ICU, excluding those already in an existing follow‐up or rehabilitation programme
1 finding from 1 review
All‐cause mortality Time point of measurement: 2 months in 1 randomised study; 12 months in 3 randomised studies; 14 months in 1 non‐randomised study · adult survivors of the ICU, excluding those already in an existing follow‐up or rehabilitation programme
1 finding from 1 review
Anxiety and depression · adult survivors of the ICU, excluding those already in an existing follow‐up or rehabilitation programme
1 finding from 1 review
Severity of PTSD symptoms · adult survivors of the ICU, excluding those already in an existing follow‐up or rehabilitation programme
1 finding from 1 review
Physical function · adult survivors of the ICU, excluding those already in an existing follow‐up or rehabilitation programme
1 finding from 1 review
Cognitive function · adult survivors of the ICU, excluding those already in an existing follow‐up or rehabilitation programme
1 finding from 1 review
Ability to return to work or education (reported at 12 months) · adult survivors of the ICU, excluding those already in an existing follow‐up or rehabilitation programme
1 finding from 1 review
Adverse effects · adult survivors of the ICU, excluding those already in an existing follow‐up or rehabilitation programme
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Anxiety · adult cancer survivors from the following cancer sites: breast, colorectal, head‐and‐neck, Hodgkin lymphoma, melanoma, non‐small cell lung…
1 finding from 1 review
no estimate extracted
180 participants
Very low
Depression · adult cancer survivors from the following cancer sites: breast, colorectal, head‐and‐neck, Hodgkin lymphoma, melanoma, non‐small cell lung…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Costs · adult cancer survivors from the following cancer sites: breast, colorectal, head‐and‐neck, Hodgkin lymphoma, melanoma, non‐small cell lung…
1 finding from 1 review
no estimate extracted
1412 participants
Very low
Overall survival · adult cancer survivors from the following cancer sites: breast, colorectal, head‐and‐neck, Hodgkin lymphoma, melanoma, non‐small cell lung…
Less intensive showed no clear difference in overall survival compared with more intensive follow‐up after primary cancer treatment (low certainty).
1 finding from 1 review
HR 1.05 [0.96, 1.14]
10726 participants
Low
Time to detection of recurrence · adult cancer survivors from the following cancer sites: breast, colorectal, head‐and‐neck, Hodgkin lymphoma, melanoma, non‐small cell lung…
Less intensive probably leads to lower time to detection of recurrence compared with more intensive follow‐up after primary cancer treatment (moderate certainty).
1 finding from 1 review
HR 0.85 [0.79, 0.92]
11276 participants
Moderate
Health‐related quality of life · adult cancer survivors from the following cancer sites: breast, colorectal, head‐and‐neck, Hodgkin lymphoma, melanoma, non‐small cell lung…
1 finding from 1 review
no estimate extracted
2742 participants
Very low